In another study, Lindsey et al. examined the feasibility of using MAX8 as a delivery system for nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF); two key neurotrophic growth factors currently used in experimental treatments of spinal cord injuries. Here, NGF is linked to spinal cord injury.